AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
about
Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic MedicationsTherapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and patient demographicsMultivariate risk assessment and risk score cards in hypertensionCardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxibHomocysteine--a novel risk factor for vascular diseaseStroke Risk Factors, Genetics, and Prevention.Citrullus lanatus 'sentinel' (watermelon) extract reduces atherosclerosis in LDL receptor-deficient mice.Considerations for using research data to verify clinical data accuracy.Community cardiovascular disease risk from cross-sectional general practice clinical data: a spatial analysis.Selection of patients for myocardial perfusion scintigraphy based on fuzzy sets theory applied to clinical-epidemiological data and treadmill test results.Issues and challenges in the assessment, diagnosis and treatment of cardiovascular risk factors: assessing the needs of cardiologistsAutologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.Clinical considerations and mechanistic determinants of postprandial lipemia in older adults.Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.Use of statin therapy to reduce cardiovascular risk in older patients.Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysisBetter detection of platelet aggregation in patients with metabolic syndrome using epinephrine and ADP.Differences in the association of cardiovascular risk factors with education: a comparison of Costa Rica (CRELES) and the USA (NHANES).Applicability of the ankle-brachial-index measurement as screening device for high cardiovascular risk: an observational study.A comprehensive view of sex-specific issues related to cardiovascular disease.Lipoprotein-associated phospholipase A2 and carotid intima-media thickness in individuals classified as low-risk according to Framingham.Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.Diagnostic and prognostic value of absence of coronary artery calcification in patients with stable chest symptoms.The Malaysian consensus statement on utilisation of cardiac CT.The association between cardiovascular risk and cardiovascular magnetic resonance measures of fibrosis: the Multi-Ethnic Study of Atherosclerosis (MESA)Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.Cardiovascular risk assessment and triptans.Postprandial spillover of dietary lipid into plasma is increased with moderate amounts of ingested fat and is inversely related to adiposity in healthy older men.Psychosocial stress and cardiovascular disease Part 2: effectiveness of the Transcendental Meditation program in treatment and prevention.Statins: another class of antihypertensive agents?Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.Practical ways to deal with the high burden of cardiovascular disease in hemodialysis patients.Formal combinations of guidelines: a requirement for self-administered personalized health education.Genetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children.Racial disparities in outcomes following coronary artery bypass grafting.Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians.Why do children from socioeconomically disadvantaged families suffer from poor health when they reach adulthood? A life-course studyAdding "value" to clinical practice guidelines.Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial.
P2860
Q26824616-3E99BD0E-EFAE-4328-879E-48133FAC4313Q28169144-FB17A1D1-5731-42DF-97C9-A204595EA269Q28219606-56591604-B759-4874-A217-AC4B325EAED4Q28222097-CF555C60-36CD-437A-9DA1-866CB0386F3DQ28353061-8080A6CE-E9F1-4B02-96F3-360DB958816DQ30238633-3AAC251C-CCDB-409B-8AD2-F42883ED3924Q30558177-671C5C28-61A9-46C8-B394-F7DE75A18591Q30900380-77CE5F2A-EF1E-48BC-8749-D1DB093D56C9Q30900391-D6595102-6833-4D54-865A-BE3962D7BBDFQ31029048-0A39E8FB-2A76-4D7E-AA04-F11922DBDEBCQ33335379-E64892DF-1AB1-4E88-92D3-727BEE15CCF6Q33462060-BC0F2730-DAFE-46FC-9CB6-25FDA861CBDCQ33578646-29B170DA-03B8-499B-A9B3-5F6DE5DB21C3Q33926274-B7F9586B-DA7E-4EA6-BB7C-8CB2A6685144Q33984593-717F7249-FC72-4906-9815-82C0970C4BF1Q34100632-98314AD1-1E32-49FE-B89A-200C940FF032Q34217242-2FAF1FFB-08ED-4C43-822A-191BF37D46DEQ34289680-795CDC71-9281-4ED1-AFFC-173870B1E619Q34356596-9C1B9B58-F623-47A1-9356-3B9C4F55D2B5Q34577461-2D58974C-9497-4E97-ADAB-3D1FF5CC597CQ34779570-5E12B522-4CBD-4795-8990-79D6421CED65Q34850830-7EFBAA98-0940-47DE-8B82-2C883B3C2CC0Q34918355-C7C8F139-C02F-443D-8513-1F94E7828D5BQ34991741-F1485FBB-8AAC-4F70-ACAA-644F6E419169Q35079303-8EDBC0A5-5476-43EF-81AE-08B1644BF97AQ35097138-5215F953-9EE2-4A03-8293-91856FC7FEEFQ35184667-BAF2C4E7-F7EC-4928-9AC3-4731A6191FC9Q35776431-3315E191-82B2-4863-900F-F36FCC18D697Q36235279-1FABCEC4-1738-4E0D-A6C8-C4D495D860A0Q36389541-518F4759-1AEB-4C98-BAE2-48113A41E25DQ36411099-59376165-187E-49BB-A34A-6DD5E96A8F01Q36440055-48CE367C-236A-4589-B4AE-DCD9CC822981Q36448347-68A26CBB-C483-436B-92AB-A6048EE1A222Q36461189-7D786323-F846-41A5-9632-8AA173DCFFF3Q36531585-AD41EC8A-C403-40AD-A785-8C79EFC26735Q36591132-BA06C3B0-AAB2-4598-81CE-02C2EE33D65DQ36766993-C8BCF56C-7C2E-49C2-A5F8-564FA9597937Q36801628-4F0020B9-7FE8-4793-8DA0-997D9ED2FA96Q36943116-B63659D7-32E5-4624-8AFD-9A0482D39D47Q36986975-911E91A1-F81E-405F-95E7-AF5E19045CD5
P2860
AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
AHA/ACC scientific statement: ...... merican College of Cardiology.
@ast
AHA/ACC scientific statement: ...... merican College of Cardiology.
@en
type
label
AHA/ACC scientific statement: ...... merican College of Cardiology.
@ast
AHA/ACC scientific statement: ...... merican College of Cardiology.
@en
prefLabel
AHA/ACC scientific statement: ...... merican College of Cardiology.
@ast
AHA/ACC scientific statement: ...... merican College of Cardiology.
@en
P2093
P1476
AHA/ACC scientific statement: ...... merican College of Cardiology.
@en
P2093
Greenland P
Pasternak R
Smith S Jr
P304
P356
10.1016/S0735-1097(99)00387-3
P407
P577
1999-10-01T00:00:00Z